. 2015 Oct 3;6(34):35813–35829. doi: 10.18632/oncotarget.5358

Table 4. Multivariate analysis of overall survival in EOC patients.

	B	Hazard ratio	95.0% CI for Exp(B)		p-value
	B	Hazard ratio	Lower	Upper	p-value
Stage (III/IV vs. I/II)	1.465	4.33	1.63	11.49	0.003
Tumor grade (II-III vs. I)	1.434	4.20	1.63	10.80	0.003
Lymph node involvement(yes vs. no)	0.691	2.00	1.19	3.35	0.009
CTHRC1 expression (high vs. low)	1.231	3.42	1.82	6.43	< 0.001